Sepsitron

company

About

Sepsitron offers a faster and cheaper point-of-care rapid diagnostic device for early detection of blood infections.

  • 1 - 10

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$250K
Industries
Biotechnology,Hardware,Health Care,Medical Device
Founded date
Nov 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Sepsitron offers 50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of blood infections. Sepsitron's technology is powered by our unique biomarkers, microfluidics, and state-of-the-art electronics to precisely identify multiple pathogens from a single test. Our tests do not require any sample pre-processing and can work with whole blood samples. Sepsitron is funded by the world's best startup accelerators - Entrepreneur First, SOSV Investments, and HAX.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$250K
Sepsitron has raised a total of $250K in funding over 2 rounds. Their latest funding was raised on Mar 23, 2020 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 23, 2020 Pre-seed 1 Detail
Nov 5, 2019 Pre-seed $250K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sepsitron is funded by 1 investors. HAX are the most recent investors.
Investor Name Lead Investor Funding Round
HAX Pre-seed